Drug Chatter -- Tracking biopharma stock chatter

💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…

Profile for Seattle Genetics, Inc. (SGEN)

« Back to company index

SGEN Chatter Timeline

Stock Ticker for SGEN

Most Active Tweeters for SGEN

UserTweets
@TheMarketsDaily 6
@FlashAlert_me 5
@TranscriptDaily 4
@sbwcws 3
@HealthcareBeat 3

Recent Tweets for SGEN

GatorStockChomp @GatorStockChomp
$SGEN before I go... daily look 20ema bounce attempt... will watch https://t.co/FYoKZcGwMo
October 19th 2020, 3:10pm
JFDI @JFDI
$irtc $sgen tossin out gifts
October 19th 2020, 2:10pm
dispatchtribune @dispatchtribune
Seattle Genetics $SGEN PT Raised to $215.00 at Bank of America https://t.co/Rq34Lb3p5h
October 19th 2020, 4:10am
OlympiaReport @OlympiaReport
Seattle Genetics $SGEN PT Raised to $215.00 at Bank of America https://t.co/IwhMrzlxI0
October 19th 2020, 4:10am
TranscriptDaily @TranscriptDaily
Seattle Genetics $SGEN Earns Buy Rating from William Blair https://t.co/hZos7ZggJo
October 19th 2020, 2:10am
dailypoliticaln @dailypoliticaln
Seattle Genetics $SGEN Receives “Buy” Rating from William Blair https://t.co/jDfqtz1Kte
October 18th 2020, 1:10am
WatchlistN @WatchlistN
William Blair Reiterates “Buy” Rating for Seattle Genetics $SGEN https://t.co/e5AMVZxxaw
October 18th 2020, 1:10am
AmericanBanking @AmericanBanking
Seattle Genetics $SGEN Receives “Buy” Rating from William Blair https://t.co/3m4OSJl86v #stocks
October 17th 2020, 11:10am
ZolmaxNews @ZolmaxNews
Seattle Genetics $SGEN PT Raised to $215.00 https://t.co/FYWf2yBKeB
October 17th 2020, 10:10am
TheMarketsDaily @TheMarketsDaily
Seattle Genetics $SGEN PT Raised to $215.00 https://t.co/qPlUQSNMKf
October 17th 2020, 10:10am
stocknewstimes @stocknewstimes
Seattle Genetics $SGEN Rating Reiterated by William Blair https://t.co/KtdTMSWAzG
October 17th 2020, 8:10am
TheMarketsDaily @TheMarketsDaily
Seattle Genetics $SGEN Receives “Buy” Rating from William Blair https://t.co/4IwIPflCmU
October 17th 2020, 6:10am
ZolmaxNews @ZolmaxNews
Seattle Genetics $SGEN Receives “Buy” Rating from William Blair https://t.co/6XlLZsdD08
October 17th 2020, 6:10am
sleekoptions @sleekoptions
$SGEN Was up 1.31 %. Turned negative -1.25 % | (Green to red move) https://t.co/Bcp52vxR0p https://t.co/siHYqdSKLz
October 16th 2020, 2:10pm
EnterpriseLeade @EnterpriseLeade
Seattle Genetics $SGEN Price Target Increased to $215.00 by Analysts at Bank of America https://t.co/hLGb12TztQ
October 16th 2020, 11:10am
stocknewstimes @stocknewstimes
Seattle Genetics $SGEN PT Raised to $216.00 https://t.co/IpFqCpSVPa
October 16th 2020, 9:10am
OlympiaReport @OlympiaReport
JMP Securities Boosts Seattle Genetics $SGEN Price Target to $216.00 https://t.co/Meh3msYvZj
October 16th 2020, 9:10am
TranscriptDaily @TranscriptDaily
JMP Securities Boosts Seattle Genetics $SGEN Price Target to $216.00 https://t.co/PdtBw3NTQ7
October 16th 2020, 9:10am
AmericanBanking @AmericanBanking
Seattle Genetics, Inc. Expected to Post FY2021 Earnings of -$1.53 Per Share $SGEN https://t.co/ySH5va1mgi #stocks
October 16th 2020, 9:10am
TheMarketsDaily @TheMarketsDaily
Seattle Genetics, Inc. Expected to Post FY2021 Earnings of -$1.53 Per Share $SGEN https://t.co/uR8GQ4GwVV
October 16th 2020, 9:10am
dakotafinancial @dakotafinancial
Seattle Genetics $SGEN PT Raised to $204.00 https://t.co/UiKclu2N3Z
October 16th 2020, 7:10am
OlympiaReport @OlympiaReport
Seattle Genetics $SGEN PT Raised to $204.00 https://t.co/8zmehyXW24
October 16th 2020, 7:10am
sleekoptions @sleekoptions
Peak profit for the last 6 expired option alerts for $SGEN -99.30% | 551.62% | 693.95% | 1.05% | 47.17% | 473.94% |… https://t.co/sXS1s6ssF0
October 16th 2020, 3:10am
sleekoptions @sleekoptions
$SGEN - Last six months, 44 option alerts peaked above 100% after they were triggered by the algo… https://t.co/zqUANAtrae
October 16th 2020, 2:10am
EnterpriseLeade @EnterpriseLeade
Seattle Genetics, Inc. to Post FY2021 Earnings of $0.48 Per Share, SVB Leerink Forecasts $SGEN https://t.co/vw12I7t0Nj
October 16th 2020, 2:10am
TheMarketsDaily @TheMarketsDaily
Seattle Genetics, Inc. to Post FY2021 Earnings of $0.48 Per Share, SVB Leerink Forecasts $SGEN https://t.co/lyNLNPnCQR
October 16th 2020, 2:10am
TranscriptDaily @TranscriptDaily
Seattle Genetics, Inc. to Post FY2021 Earnings of $0.48 Per Share, SVB Leerink Forecasts $SGEN https://t.co/BiC5RdVRly
October 16th 2020, 2:10am
CarlyHFierce @CarlyHFierce
Merck's Keytruda scores solo lymphoma nod, but analysts are fixed on Seagen's combo potential: https://t.co/8vOqpQORfp $MRK $SGEN #pharma
October 15th 2020, 2:10pm
stocknewstimes @stocknewstimes
Seattle Genetics $SGEN Price Target Increased to $215.00 by Analysts at Bank of America https://t.co/ua1pyvOLj4
October 15th 2020, 11:10am
TranscriptDaily @TranscriptDaily
Seattle Genetics $SGEN PT Raised to $215.00 https://t.co/HclgqyWOU2
October 15th 2020, 11:10am
TheMarketsDaily @TheMarketsDaily
SVB Leerink Boosts Seattle Genetics $SGEN Price Target to $204.00 https://t.co/imPNzNb9wg
October 15th 2020, 4:10am
JacobPlieth @JacobPlieth
Discontinuations: RG7861 (anti S aureus ADC?) partnered with $SGEN. RG6000 = dual leucine zipper kinase inhibitor for ALS. $RHHBY
October 15th 2020, 4:10am
TheMarketsDaily @TheMarketsDaily
Seattle Genetics $SGEN PT Raised to $216.00 at JMP Securities https://t.co/dWdn7crWHy
October 15th 2020, 4:10am
ThisLincolnian @ThisLincolnian
Seattle Genetics $SGEN PT Raised to $216.00 at JMP Securities https://t.co/i5IHbOAGCL
October 15th 2020, 4:10am
Gambiste1 @Gambiste1
RT @Pbagri10: $SGEN - developing Monoclonal antibody treatment for cancer treatment. A new modality for cancer treatment. Buy @ $210 #Stocks
October 14th 2020, 7:10pm
ofthegreen @ofthegreen
@semodough Important to note that for $SGEN it will be their inaugural R&D day. Clay on record as saying he does n… https://t.co/Q8tqcpcECL
October 14th 2020, 6:10pm
ofthegreen @ofthegreen
@Sports_bios All aboard the $SGEN locomotive. Plenty of ride left. Talk about a company that executes (CEO Clay is… https://t.co/ksMpgE8XqG
October 14th 2020, 6:10pm
Pbagri10 @Pbagri10
$SGEN - developing Monoclonal antibody treatment for cancer treatment. A new modality for cancer treatment. Buy @ $210 #Stocks
October 14th 2020, 2:10pm
AmericanBanking @AmericanBanking
SVB Leerink Equities Analysts Boost Earnings Estimates for Seattle Genetics, Inc. $SGEN https://t.co/1xtSXe0D4q #stocks
October 14th 2020, 6:10am
WatchlistN @WatchlistN
Seattle Genetics $SGEN Price Target Increased to $216.00 by Analysts at JMP Securities https://t.co/VtZ8d5SMlE
October 14th 2020, 4:10am
portefeuillefun @portefeuillefun
Sold 70 $SGEN at $213.19, now 180 #vssporte shares.
October 13th 2020, 3:10pm
BioEqman @BioEqman
$SGEN Overvalued.. time to buy puts
October 13th 2020, 12:10pm
HelixBioPharma @HelixBioPharma
Seagen, Astellas eye earlier Padcev use in bladder cancer with long-lasting phase 2 results! $SGEN $ALPMY #cancer… https://t.co/RhqOn6B4cx
October 13th 2020, 9:10am
jodietheai @jodietheai
$SGEN: Seagen and Astellas announce positive topline results from the second cohort of patients in the pivotal pha… https://t.co/JAPMnM8uDS
October 13th 2020, 7:10am
EdgarInsider @EdgarInsider
Alert [Press/News Current Report] / Form 8-K filed with the SEC $SGEN Seagen Inc https://t.co/I11ZgA2Uhg
October 13th 2020, 7:10am
fintel_io @fintel_io
$SGEN / Seattle Genetics files form 8-K - Financial Statements and Exhibits, Other Events - 8-K https://t.co/3mw0rBmcrN
October 13th 2020, 7:10am
FlashAlert_me @FlashAlert_me
$SGEN [15s. delayed] filed form 8-K on October 13, 07:31:54: Item8.01: Other Material Events https://t.co/el6tqGByMt
October 13th 2020, 7:10am
TargetPrices @TargetPrices
$SGEN Target Raised by SVB Leerink Outperform USD 187 » USD 204 https://t.co/6fqC7RU6BO
October 12th 2020, 3:10pm
QuantchaIdeas @QuantchaIdeas
52-Week High Alert: Trading today’s movement in SEATTLE GENETICS $SGEN https://t.co/UTzsb6JPRJ
October 12th 2020, 12:10pm
SlingshotCtlyst @SlingshotCtlyst
Topline Results from Second Cohort of Patients in Phase 2 Pivotal Trial of PADCEV Released $SGEN , $ALPMY https://t.co/gWnQ8nnwLi
October 12th 2020, 11:10am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2020. All rights reserved.